Natco Pharma to Raise Stake in South Africa's Adcock Ingram to 49% in Rs 1,069 Crore Deal
New Delhi: NATCO Pharma Limited has received approval from its Board of Directors to acquire an additional stake in South Africa-based Adcock Ingram Holdings Proprietary Limited, increasing its shareholding from 35.75% to 49%.
The acquisition, valued at approximately Rs 1,069 crore at the prevailing exchange rate, is subject to customary closing conditions and statutory approvals.
According to the company, Adcock Ingram reported revenue of USD 423 million and an EBITDA of approximately USD 59 million for the nine-month period ended March 31, 2026.
Following the completion of the transaction, NATCO Pharma will recognise 49% of Adcock Ingram's profit after tax in its financial statements, reflecting its increased equity stake in the South African pharmaceutical company.
